Share
In this year’s Society for Neuroscience meeting, about 1,000 brain scientists packed the San Diego Convention Center for the symposium, called Psychedelics and Neural Plasticity. They heard about how drugs like MDMA and psilocybin can help rewire the brain, offering a new way to treat disorders from depression to chronic pain. “In the last couple of years there has been a lot of public excitement about psychedelics,” says Alex Kwan, a biomedical engineer at Cornell University who was also a speaker at the event. Kwan and other researchers spoke about what they’ve learned about the drugs.
Kwan described his work on psilocybin, the active ingredient in magic mushrooms. He says the drug seems to help rewire the brain by creating new connections between neurons.
Psychedelics being featured at the world’s largest meeting of brain scientist is a recent development as the drugs begin to enter the scientific mainstream.
Read more at NPR
RELATED TOPICS:
Senate Confirms Mehmet Oz to Take Lead of Medicare and Medicaid Agency
2 hours ago
First California EV Mandates Hit Automakers This Year. Most Are Not Even Close
4 hours ago
Pence Will Receive the Profile in Courage Award From the JFK Library for His Actions on Jan. 6
4 hours ago
Pentagon’s Watchdog to Review Hegseth’s Use of Signal App to Convey Plans for Houthi Strike
4 hours ago
President Trump’s Tariffs Could Be the Political Tipping Point
5 hours ago
Order That Kept Water in the Kern River Reversed by 5th District Court of Appeal
5 hours ago
As Dem Candidates for Governor Increase, They Wait for Harris to Decide
5 hours ago
China Halts Approvals for New US Investment Projects
10 minutes ago
Categories

China Halts Approvals for New US Investment Projects

Trump Tariff Fears Erase $2 Trillion From US Stocks

Senate Confirms Mehmet Oz to Take Lead of Medicare and Medicaid Agency

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close
